Effect of glargine insulin delivery method (pen device versus vial/syringe) on glycemic control and patient preferences in patients with type 1 and type 2 diabetes.

Find People
Find Research
Overview
Tutorials
FAQs
Edit My PROFILE
Login to PROFILES

Contact Us
If you have any questions or feedback please contact us.

Effect of glargine insulin delivery method (pen device versus vial/syringe) on glycemic control and patient preferences in patients with type 1 and type 2 diabetes.

Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Wang CC, Draznin B. Effect of glargine insulin delivery method (pen device versus vial/syringe) on glycemic control and patient preferences in patients with type 1 and type 2 diabetes. Endocr Pract. 2014 Jun; 20(6):536-9.

View in: PubMed

subject areas

Adult
Aged
Blood Glucose
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Female
Humans
Hypoglycemic Agents
Insulin Glargine
Male
Middle Aged
Patient Preference

authors with profiles

Stacey Ann Seggelke
Boris Draznin
Neda Rasouli
R. Matthew Hawkins PAC

Contact Us
CCTSI
About CCTSI
CCTSI Affiliated Institutions
National CTSA Consortium